Global COVID-19 Diagnostics Market Outlook (2018 to 2027) - Featuring Abbott Diagnostics, BioFire Diagnostics & Cepheid Among Others - ResearchAndMarkets.com

DUBLIN--()--The "COVID-19 Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

The Global COVID-19 Diagnostics market accounted for $16.13 billion in 2018 and is expected to reach $31.18 billion by 2027 growing at a CAGR of 7.6% during the forecast period.

Rise in the number of cases of COVID-19 patients across the globe and requirement to ensure accurate test results are the major factors driving the market growth. However, lack of knowledge about the coronavirus, its symptoms, and its ability to spread is restraining the market growth.

COVID-19 is an infectious disease caused due to the coronavirus. Its symptoms include mild to moderate respiratory discomfort. While most may recover without any need for special treatment, the virus can cause major issues or serious illness and even death in older individuals and persons with underlying medical problems such as diabetes and cancers. As it has been the cause of numerous deaths, and infections in the past there is an urgent need for accurate diagnostic methods.

Based on test type, the molecular segment is likely to have a huge demand as it involves the extraction of viral RNA from a patient's sample and synthesis of the complementary DNA (cDNA) followed by amplification of the viral genome. By geography, North America is going to have a lucrative growth during the forecast period due to the well-established healthcare system and several pharmaceutical companies.

Companies Mentioned

  • Alveo Technologies
  • Accelerate Diagnostics
  • Abbott Diagnostics
  • Aus Diagnostics
  • Ador Diagnostics
  • Akkoni Biosystems
  • Applied BioCode
  • BD Diagnostics
  • Cue Health
  • Biocartis
  • Co-Diagnostics
  • BioFire Diagnostics
  • Cepheid
  • bioMerieux
  • Bosch Healthcare Solutions GmbH
  • Bio-Rad Laboratories
  • Curetis
  • GenePOC Diagnostics
  • Diagenode Diagnostics
  • GenMark Dx

What the report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface

2.1 Abstract

2.2 Stake Holders

2.3 Research Scope

2.4 Research Methodology

2.4.1 Data Mining

2.4.2 Data Analysis

2.4.3 Data Validation

2.4.4 Research Approach

2.5 Research Sources

2.5.1 Primary Research Sources

2.5.2 Secondary Research Sources

2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 End User Analysis

3.7 Emerging Markets

3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global COVID-19 Diagnostics Market, By Quantity of User

5.1 Introduction

5.2 Multiple

5.3 Single

6 Global COVID-19 Diagnostics Market, By Test Type

6.1 Introduction

6.2 Serology

6.3 Molecular

7 Global COVID-19 Diagnostics Market, By End User

7.1 Introduction

7.2 Public Health Labs

7.3 Private or Commercial Labs

7.4 Physician Labs

7.5 Hospitals

8 Global COVID-19 Diagnostics Market, By Geography

8.1 Introduction

8.2 North America

8.2.1 US

8.2.2 Canada

8.2.3 Mexico

8.3 Europe

8.3.1 Germany

8.3.2 UK

8.3.3 Italy

8.3.4 France

8.3.5 Spain

8.3.6 Rest of Europe

8.4 Asia Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 New Zealand

8.4.6 South Korea

8.4.7 Rest of Asia Pacific

8.5 South America

8.5.1 Argentina

8.5.2 Brazil

8.5.3 Chile

8.5.4 Rest of South America

8.6 Middle East & Africa

8.6.1 Saudi Arabia

8.6.2 UAE

8.6.3 Qatar

8.6.4 South Africa

8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures

9.2 Acquisitions & Mergers

9.3 New Product Launch

9.4 Expansions

9.5 Other Key Strategies

10 Company Profiling

For more information about this report visit https://www.researchandmarkets.com/r/59uhho

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900